A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

IsraelRecruitingPHASE1, PHASE2

Conditions

Solid Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Christiana Care Health System- Site Number : 8400011, Newark, Delaware, United States
Contact: Study coordinator (Jamal Misleh) · Jamal.misleh@usoncology.com · 302-366-1200
Contact: Principal Investigator (Jamal Misleh)
University of Iowa- Site Number : 8400014, Iowa City, Iowa, United States
Contact: Study coordinator (Muhammad Furquan) · muhammad-furqan@uiowa.edu · 319-356-1527
Contact: Principal Investigator (Muhammad Furquan)
University of Kansas Cancer Center Clinical Research Center (Fairway) Site Number : 8400008, Fairway, Kansas, United States
Contact: Study coordinator (Lisa Bogart) · CTNurseNav@kumc.edu · 913-945-7552
Contact: Principal Investigator (Joaquina Baranda)
Barbara Ann Karmanos Cancer Institute - Detroit- Site Number : 8400006, Detroit, Michigan, United States
Contact: Study coordinator (Ammar Sukari) · sukaria@karmanos.org · 313-576-8751
Contact: Principal Investigator (Ammar Sukari)
John Theurer Cancer Center Site Number : 8400001, Hackensack, New Jersey, United States
Contact: Study coordinator (Suzanne Kosky) · suzanne.kosky@hmhn.org · 551-996-3986
Contact: Principal Investigator (Martin Gutierrez)
NYU Langone Medical Center-New York- 550 1st Ave - BRANY - PPDS- Site Number : 8400013, New York, New York, United States
Contact: Study coordinator (Paul Oberstein) · paul.oberstein@nyulangone.org · 212-731-6120
Contact: Principal Investigator (Paul Oberstein)
Rhode Island Hospital Site Number : 8400004, Providence, Rhode Island, United States
Contact: Study coordinator (Kaitlyn Krar) · CKrar@Lifespan.org · 401-444-4818
Contact: Principal Investigator (Khaldoun Almhanna)
University of Texas MD Anderson Cancer Center Site Number : 8400005, Houston, Texas, United States
Contact: Study coordinator (Aung Naing) · anaing@mdanderson.org · 713-794-5555
Contact: Principal Investigator (Aung Naing)
Fred Hutchinson Cancer Center - 825 Eastlake Ave E- Site Number : 8400010, Seattle, Washington, United States
Contact: Study coordinator (Elena Chiorean) · gchiorea@seattlecca.org · 206-606-6248
Contact: Principal Investigator (Elena Chiorean)
Servicios Médicos URUMED SpA_Investigational Site Number : 1520002, Rancagua, General Bernardo O'Higgins, Chile
Contact: Study coordinator (Plinio Fernandez) · pliniofernandez@urumed.cl · 56 9 8902 2206
Contact: Principal Investigator (Plinio Fernandez)
BIOCINETIC Ltda_Investigational Site Number : 1520008, Santiago, Reg Metropolitana de Santiago, Chile
Contact: Study coordinator (Nicolas Obando Martínez) · nicolas.obando@cecim.cl · 569 90790781
Contact: Principal Investigator (Nicolas Obando Martínez)
Fundacion Arturo Lopez Perez (FALP) - Providencia - Jose Manuel Infante 805_Investigational Site Number : 1520007, Providencia, Chile
Contact: Study coordinator (Christian Caglevic Medina) · christian.caglevic@falp.org · (562) 242-0509
Contact: Principal Investigator (Christian Caglevic Medina)
Centro de Investigacion Clinica Bradford Hill_Investigational Site Number : 1520004, Recoleta, Chile
Contact: Study coordinator (Carlos Ignacio Rojas Garcia) · cirojas@bh.cl · 56 9 9874 4662
Contact: Principal Investigator (Carlos Ignacio Rojas Garcia)
Hadassah Medical Center - PPDS_Investigational Site Number : 3760005, Jerusalem, Jerusalem, Israel
Contact: Study coordinator (Jonathan Cohen) · cohenjon@hadassah.org.il · 972505172537
Contact: Principal Investigator (Jonathan Cohen)
Shamir Medical Center_Investigational Site Number : 3760004, Be’er Ya‘aqov, Israel
Contact: Study coordinator (Carmell Fink) · carmelf@shamir.gov.il · 972584882432
Contact: Principal Investigator (Carmell Fink)
Sheba Medical Center - PPDS_Investigational Site Number : 3760003, Ramat Gan, Israel
Contact: Study coordinator (Tamar Beller) · Tamar.Beller@sheba.health.gov.il · 972545964434
Contact: Principal Investigator (Tamar Beller)
Tel Aviv Sourasky Medical Center Ichilov - PPDS_Investigational Site Number : 3760001, Tel Aviv, Israel
Contact: Study coordinator (Ravit Geva) · ravitg@tlvmc.gov.il · 97236973494
Contact: Principal Investigator (Ravit Geva)
Investigational Site Number : 3920001, Kashiwa-Shi, Japan
Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis_Investigational Site Number : 5280001, Amsterdam, North Holland, Netherlands
Contact: Study coordinator (Marloes van Dongen) · mg.v.dongen@nki.nl · 31205129111
Contact: Principal Investigator (Marloes van Dongen)
Erasmus MC_Investigational Site Number : 5280003, Rotterdam, South Holland, Netherlands
Contact: Study coordinator (Ferry Eskens) · f.eskens@erasmusmc.nl · 31107034897
Contact: Principal Investigator (Ferry Eskens)
Instituto de Investigacion Oncologica Vall d'Hebron (VHIO) - EPON_Investigational Site Number : 7240007, Barcelona, Spain
Contact: Study coordinator (Elena Garralda) · egarralda@vhio.net · 34932746085
Contact: Principal Investigator (Elena Garralda)
START MADRID_Hospital Universitario HM Sanchinarro - CIOCC_Investigational Site Number : 7240005, Madrid, Spain
Contact: Study coordinator (Emiliano Calvo) · emiliano.calvo@startmadrid.com · 34917567825
Contact: Principal Investigator (Emiliano Calvo)

Study leads

Clinical Sciences & Operations
Study Director
Sanofi

View source on ClinicalTrials.gov Contact study team (email)